Medpace Holdings, Inc. Increase (Decrease) in Restricted Cash for Operating Activities
Medpace Holdings, Inc. (MEDP) reported Increase (Decrease) in Restricted Cash for Operating Activities of $506.00 thousand for the 9-month period ending 2016-09-30, per its 10-Q filed 2016-11-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCashForOperatingActivities · last filed 2016-11-03
- 2016-09-30: Increase (Decrease) in Restricted Cash for Operating Activities 9 month $506.00K.
- 2015-09-30: Increase (Decrease) in Restricted Cash for Operating Activities 9 month $1.22M.
| Period end | Increase (Decrease) in Restricted Cash for Operating Activities 9 month |
|---|---|
| 2016-09-30 | $506.00K 10-Q · filed 2016-11-03 |
| 2015-09-30 | $1.22M 10-Q · filed 2016-11-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |